Abstract |
The exclusive distribution of 5-HT6 receptor in the brain regions and high affinity for antipsychotic and antidepressant drugs makes 5-HT6 receptor a promising target in treatment of CNS diseases. Based on a pharmacophore model reported in the literature, we designed and synthesized a novel series of 5-HT6 receptor ligands having indole as a central aromatic core and 1-amino-4-methyl piperazine as positive ionizable group. Out of 32 compounds we have successfully identified 10 new compounds as 5-HT6 receptor antagonists. The structure-activity relationship (SAR) studies have been carried out by mapping the compounds with the 3D QSAR model.
|
Authors | Faisal Hayat, Sungjin Cho, Hyewhon Rhim, Ambily Nath Indu Viswanath, Ae Nim Pae, Jae Yeol Lee, Dong Joon Choo, Hea-Young Park Choo |
Journal | Bioorganic & medicinal chemistry
(Bioorg Med Chem)
Vol. 21
Issue 17
Pg. 5573-82
(Sep 01 2013)
ISSN: 1464-3391 [Electronic] England |
PMID | 23810425
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Copyright | Copyright © 2013 Elsevier Ltd. All rights reserved. |
Chemical References |
- Indoles
- Ions
- Ligands
- Piperazines
- Receptors, Serotonin
- Recombinant Proteins
- Serotonin Antagonists
- serotonin 6 receptor
- Piperazine
- indole
|
Topics |
- Algorithms
- Drug Design
- HEK293 Cells
- Humans
- Indoles
(chemistry)
- Ions
(chemistry)
- Ligands
- Piperazine
- Piperazines
(chemistry)
- Protein Binding
- Quantitative Structure-Activity Relationship
- Receptors, Serotonin
(chemistry, genetics, metabolism)
- Recombinant Proteins
(biosynthesis, chemistry, genetics)
- Serotonin Antagonists
(chemical synthesis, chemistry, metabolism)
- Structure-Activity Relationship
|